BLFS
BioLife Solutions, Inc.
Price Chart
Latest Quote
$25.86
+0.29 (+1.11%)
Current Price
| Previous Close | $25.58 |
| Open | $26.03 |
| Day High | $26.83 |
| Day Low | $25.80 |
| Volume | 108,348 |
Stock Information
| Shares Outstanding | 48.86M |
| Total Debt | $14.86M |
| Cash Equivalents | $81.00M |
| Revenue | $101.66M |
| Net Income | $-11.21M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $1.26B |
| EPS (TTM) | $-0.24 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.22B |
| Sales | $101.66M |
| Income | $-11.21M |
| Book/sh | $7.62 |
| Cash/sh | $1.66 |
| Employees | 155 |
Financial Ratios
| Quick Ratio | 5.15 |
| Current Ratio | 7.30 |
| Debt/Eq | 3.99 |
Returns & Margins
| ROA | -0.09% |
| ROE | -3.09% |
| Gross Margin | 63.76% |
| Operating Margin | 0.10% |
| Profit Margin | -2.91% |
Ownership
| Insider Ownership | 2.38% |
| Institutional Ownership | 104.51% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 89.19 |
| PEG | 15.09 |
| P/S | 12.43 |
| P/B | 3.39 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $32.30 |
Technical Indicators
| SMA20 | $26.00 |
| SMA50 | $23.28 |
| SMA200 | $23.97 |
| RSI | 55.34 |
| ATR | 1.4343 |
| Shares Float | 42.62M |
| Short Float | 12.74% |
| Short Ratio | 6.75 |
| Volatility | 1.97 |
| Rel Volume | 0.15 |
Performance History
| Week | -2.76% |
| Month | +12.21% |
| Quarter | +32.44% |
| 6 Months | +5.10% |
| YTD | +8.27% |
| Year | +18.97% |
| 3 Years | +6.27% |
| 5 Years | -31.93% |
| 10 Years | +1467.58% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $25.86 | 108,348 |
| 2026-06-17 | $25.58 | 872,200 |
| 2026-06-16 | $26.36 | 487,000 |
| 2026-06-15 | $26.69 | 829,400 |
| 2026-06-12 | $26.10 | 695,500 |
| 2026-06-11 | $26.60 | 503,900 |
| 2026-06-10 | $26.66 | 433,400 |
| 2026-06-09 | $27.55 | 712,800 |
| 2026-06-08 | $26.10 | 456,500 |
| 2026-06-05 | $26.65 | 701,900 |
| 2026-06-04 | $27.09 | 520,100 |
| 2026-06-03 | $27.25 | 847,400 |
| 2026-06-02 | $27.49 | 1,332,000 |
| 2026-06-01 | $26.63 | 1,258,700 |
| 2026-05-29 | $24.92 | 904,600 |
| 2026-05-28 | $25.25 | 541,000 |
| 2026-05-27 | $24.50 | 723,800 |
| 2026-05-26 | $24.03 | 754,900 |
| 2026-05-22 | $23.95 | 999,900 |
| 2026-05-21 | $24.74 | 1,074,800 |
| 2026-05-20 | $24.00 | 1,342,000 |
| 2026-05-19 | $23.05 | 1,081,800 |
| 2026-05-18 | $22.30 | 972,800 |
About BioLife Solutions, Inc.
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
đ° Latest News
What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold?
Insider Monkey âĸ 2026-06-18T13:54:34Z
BioLife Solutions Leads 3 Stocks Estimated To Be Trading Below Fair Value
Simply Wall St. âĸ 2026-06-04T11:38:14Z
Orthofix Medical and 5 More Stocks See Action From Activist Investors
Barrons.com âĸ 2026-05-29T21:14:00Z
A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term Momentum
Simply Wall St. âĸ 2026-05-11T01:13:08Z
BioLife (BLFS) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-08T14:21:18Z
BioLife Solutions, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-08T12:30:00Z
BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates
Zacks âĸ 2026-05-07T23:05:23Z
BioLife Solutions Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T21:39:36Z
Three Stocks Estimated To Be Trading Below Intrinsic Value In May 2026
Simply Wall St. âĸ 2026-05-07T17:38:24Z
Identifying May 2026 Stocks Trading Below Estimated Value
Simply Wall St. âĸ 2026-05-07T11:38:11Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $29,672,000 | $16,153,000 | $15,435,000 | $16,846,000 |
| Cost Of Revenue | $34,096,000 | $24,551,000 | $26,698,000 | $29,328,000 |
| Total Revenue | $96,214,000 | $74,647,000 | $68,016,000 | $76,239,000 |
| Operating Revenue | $96,214,000 | $74,647,000 | $68,016,000 | $76,239,000 |
| Expenses | ||||
| Total Expenses | $112,816,000 | $79,124,000 | $87,414,000 | $86,916,000 |
| Other Income Expense | $1,815,000 | $-3,580,000 | $8,583,000 | $6,113,000 |
| Other Non Operating Income Expenses | $1,815,000 | $494,000 | $1,275,000 | $662,000 |
| Net Non Operating Interest Income Expense | $2,706,000 | $-766,000 | $-1,406,000 | $-284,000 |
| Total Other Finance Cost | $-2,706,000 | $766,000 | $1,406,000 | $284,000 |
| Operating Expense | $78,720,000 | $54,573,000 | $60,716,000 | $57,588,000 |
| Selling And Marketing Expense | $9,850,000 | $8,932,000 | $11,377,000 | $11,672,000 |
| General And Administrative Expense | $45,520,000 | $40,627,000 | $42,792,000 | $33,255,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-12,130,000 | $-8,785,000 | $-12,157,000 | $388,000 |
| Net Interest Income | $2,706,000 | $-766,000 | $-1,406,000 | $-284,000 |
| Normalized Income | $-12,130,000 | $-4,727,296 | $-19,391,920 | $-4,844,960 |
| Net Income From Continuing And Discontinued Operation | $-4,595,000 | $-20,184,000 | $-68,002,000 | $-139,805,000 |
| Total Operating Income As Reported | $-16,602,000 | $-4,477,000 | $-17,205,000 | $-5,923,000 |
| Net Income Common Stockholders | $-4,595,000 | $-20,184,000 | $-68,002,000 | $-139,805,000 |
| Net Income | $-4,595,000 | $-20,184,000 | $-68,002,000 | $-139,805,000 |
| Net Income Including Noncontrolling Interests | $-4,595,000 | $-20,184,000 | $-68,002,000 | $-139,805,000 |
| Net Income Discontinuous Operations | $7,535,000 | $-11,399,000 | $-55,845,000 | $-140,193,000 |
| Net Income Continuous Operations | $-12,130,000 | $-8,785,000 | $-12,157,000 | $388,000 |
| Pretax Income | $-12,081,000 | $-8,823,000 | $-12,221,000 | $-4,848,000 |
| Special Income Charges | $0 | $0 | $7,308,000 | $4,754,000 |
| Operating Income | $-16,602,000 | $-4,477,000 | $-19,398,000 | $-10,677,000 |
| Depreciation Amortization Depletion Income Statement | $263,000 | $263,000 | $1,032,000 | $3,990,000 |
| Depreciation And Amortization In Income Statement | $263,000 | $263,000 | $1,032,000 | $3,990,000 |
| Amortization Of Intangibles Income Statement | $263,000 | $263,000 | $1,032,000 | $3,990,000 |
| Gross Profit | $62,118,000 | $50,096,000 | $41,318,000 | $46,911,000 |
| Average Dilution Earnings | - | - | - | $0 |
| Earnings From Equity Interest | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-0.10 | $-0.44 | $-1.55 | $-3.29 |
| Basic EPS | $-0.09 | $-0.44 | $-1.55 | $-3.29 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-16,296 | $73,080 | $218,040 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-11,915,000 | $8,258,000 | $-14,411,000 | $344,000 |
| Total Unusual Items | $0 | $-4,074,000 | $7,308,000 | $5,451,000 |
| Total Unusual Items Excluding Goodwill | $0 | $-4,074,000 | $7,308,000 | $5,451,000 |
| Reconciled Depreciation | $4,687,000 | $8,661,000 | $12,295,000 | $16,472,000 |
| EBITDA (Bullshit earnings) | $-11,915,000 | $4,184,000 | $-7,103,000 | $5,795,000 |
| EBIT | $-16,602,000 | $-4,477,000 | $-19,398,000 | $-10,677,000 |
| Diluted Average Shares | $48,645,084 | $46,067,073 | $43,719,185 | $42,481,027 |
| Basic Average Shares | $47,753,824 | $46,067,073 | $43,719,185 | $42,481,027 |
| Diluted NI Availto Com Stockholders | $-4,595,000 | $-20,184,000 | $-68,002,000 | $-139,805,000 |
| Tax Provision | $49,000 | $-38,000 | $-64,000 | $-5,236,000 |
| Restructuring And Mergern Acquisition | $0 | $0 | $-7,308,000 | $-4,754,000 |
| Amortization | $263,000 | $263,000 | $1,032,000 | $3,990,000 |
| Research And Development | $23,087,000 | $4,751,000 | $5,515,000 | $8,671,000 |
| Selling General And Administration | $55,370,000 | $49,559,000 | $54,169,000 | $44,927,000 |
| Other Gand A | $45,520,000 | $40,627,000 | $42,792,000 | $33,255,000 |
| Gain On Sale Of Security | - | $-4,074,000 | - | $697,000 |
| Impairment Of Capital Assets | - | - | $15,485,000 | $110,364,000 |
| Otherunder Preferred Stock Dividend | - | - | - | $0 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $159,044,000 | $134,757,000 | $113,363,000 | $107,359,000 |
| Total Assets | $405,884,000 | $399,487,000 | $412,714,000 | $450,229,000 |
| Total Non Current Assets | $269,323,000 | $250,726,000 | $292,110,000 | $311,777,000 |
| Other Non Current Assets | $3,050,000 | $14,424,000 | $49,626,000 | $9,064,000 |
| Investmentin Financial Assets | $31,250,000 | $4,628,000 | $548,000 | $1,332,000 |
| Goodwill And Other Intangible Assets | $212,844,000 | $214,152,000 | $224,300,000 | $256,829,000 |
| Other Intangible Assets | $4,257,000 | $5,565,000 | $11,996,000 | $32,088,000 |
| Current Assets | $136,561,000 | $148,761,000 | $120,604,000 | $138,452,000 |
| Other Current Assets | $9,526,000 | $5,952,000 | $4,667,000 | $6,879,000 |
| Assets Held For Sale Current | $0 | $4,584,000 | $36,691,000 | - |
| Inventory | $30,155,000 | $29,013,000 | $27,164,000 | $34,904,000 |
| Receivables | $7,953,000 | $8,476,000 | $7,898,000 | $33,936,000 |
| Accounts Receivable | $7,953,000 | $8,476,000 | $7,898,000 | $33,936,000 |
| Allowance For Doubtful Accounts Receivable | $-22,000 | $-152,000 | $-1,603,000 | $-739,000 |
| Gross Accounts Receivable | $7,975,000 | $8,628,000 | $9,501,000 | $34,675,000 |
| Cash Cash Equivalents And Short Term Investments | $88,927,000 | $100,736,000 | $44,184,000 | $62,702,000 |
| Cash And Cash Equivalents | $33,038,000 | $91,538,000 | $27,896,000 | $19,442,000 |
| Non Current Prepaid Assets | - | - | $273,000 | $281,000 |
| Restricted Cash | - | - | $31,000 | $31,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $17,897,000 | $30,044,000 | $33,827,000 | $43,713,000 |
| Long Term Debt And Capital Lease Obligation | $10,657,000 | $17,642,000 | $26,256,000 | $38,881,000 |
| Current Debt And Capital Lease Obligation | $7,240,000 | $12,402,000 | $7,571,000 | $4,832,000 |
| Current Debt | $4,997,000 | $10,943,000 | $6,285,000 | $1,814,000 |
| Other Current Borrowings | $4,997,000 | $10,943,000 | $6,285,000 | $1,814,000 |
| Long Term Debt | - | $4,997,000 | $17,561,000 | $23,793,000 |
| Net Debt | - | - | - | $6,165,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $33,996,000 | $50,578,000 | $75,051,000 | $86,041,000 |
| Total Non Current Liabilities Net Minority Interest | $11,017,000 | $17,844,000 | $32,873,000 | $41,459,000 |
| Other Non Current Liabilities | $171,000 | - | - | $2,328,000 |
| Liabilities Heldfor Sale Non Current | $0 | $78,000 | $6,503,000 | - |
| Non Current Deferred Liabilities | $189,000 | $124,000 | $114,000 | $250,000 |
| Non Current Deferred Taxes Liabilities | $189,000 | $124,000 | $114,000 | $250,000 |
| Current Liabilities | $22,979,000 | $32,734,000 | $42,178,000 | $44,582,000 |
| Current Deferred Liabilities | $195,000 | $103,000 | $41,000 | $548,000 |
| Payables And Accrued Expenses | $9,611,000 | $14,785,000 | $13,554,000 | $23,621,000 |
| Payables | $3,765,000 | $7,593,000 | $6,934,000 | $20,493,000 |
| Total Tax Payable | $2,279,000 | $4,233,000 | $4,664,000 | $5,126,000 |
| Accounts Payable | $1,486,000 | $3,360,000 | $2,270,000 | $15,367,000 |
| Other Current Liabilities | - | $616,000 | $18,816,000 | $2,189,000 |
| Equity | ||||
| Common Stock Equity | $371,888,000 | $348,909,000 | $337,663,000 | $364,188,000 |
| Total Equity Gross Minority Interest | $371,888,000 | $348,909,000 | $337,663,000 | $364,188,000 |
| Stockholders Equity | $371,888,000 | $348,909,000 | $337,663,000 | $364,188,000 |
| Gains Losses Not Affecting Retained Earnings | $132,000 | $24,000 | $-345,000 | $-679,000 |
| Other Equity Adjustments | $132,000 | $24,000 | $-345,000 | $-679,000 |
| Retained Earnings | $-339,696,000 | $-335,101,000 | $-314,917,000 | $-246,915,000 |
| Long Term Equity Investment | $0 | $995,000 | $5,069,000 | $5,069,000 |
| Other | ||||
| Ordinary Shares Number | $48,198,928 | $46,906,765 | $45,167,225 | $42,832,231 |
| Share Issued | $48,198,928 | $46,906,765 | $45,167,225 | $42,832,231 |
| Tangible Book Value | $159,044,000 | $134,757,000 | $113,363,000 | $107,359,000 |
| Invested Capital | $376,885,000 | $364,849,000 | $361,509,000 | $389,795,000 |
| Working Capital | $113,582,000 | $116,027,000 | $78,426,000 | $93,870,000 |
| Capital Lease Obligations | $12,900,000 | $14,104,000 | $9,981,000 | $18,106,000 |
| Total Capitalization | $371,888,000 | $353,906,000 | $355,224,000 | $387,981,000 |
| Additional Paid In Capital | $711,404,000 | $683,939,000 | $652,880,000 | $611,739,000 |
| Capital Stock | $48,000 | $47,000 | $45,000 | $43,000 |
| Common Stock | $48,000 | $47,000 | $45,000 | $43,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $10,657,000 | $12,645,000 | $8,695,000 | $15,088,000 |
| Current Deferred Revenue | $195,000 | $103,000 | $41,000 | $548,000 |
| Current Capital Lease Obligation | $2,243,000 | $1,459,000 | $1,286,000 | $3,018,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,933,000 | $4,828,000 | $2,196,000 | $5,080,000 |
| Current Accrued Expenses | $5,846,000 | $7,192,000 | $6,620,000 | $3,128,000 |
| Investments And Advances | $31,250,000 | $5,623,000 | $5,617,000 | $6,401,000 |
| Available For Sale Securities | $31,250,000 | $4,628,000 | $548,000 | $1,332,000 |
| Goodwill | $208,587,000 | $208,587,000 | $212,304,000 | $224,741,000 |
| Net PPE | $22,179,000 | $16,527,000 | $12,567,000 | $39,202,000 |
| Accumulated Depreciation | $-4,934,000 | $-4,158,000 | $-4,263,000 | $-9,171,000 |
| Gross PPE | $27,113,000 | $20,685,000 | $16,830,000 | $48,373,000 |
| Leases | $3,507,000 | $3,527,000 | $3,503,000 | $5,249,000 |
| Construction In Progress | $11,268,000 | $2,419,000 | $2,513,000 | $5,095,000 |
| Other Properties | $12,073,000 | $14,472,000 | $10,218,000 | $36,121,000 |
| Machinery Furniture Equipment | $265,000 | $267,000 | $596,000 | $1,908,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $13,223,000 | $13,163,000 | $9,021,000 | $8,274,000 |
| Work In Process | $6,371,000 | $4,082,000 | $3,475,000 | $5,680,000 |
| Raw Materials | $10,561,000 | $11,768,000 | $14,668,000 | $20,950,000 |
| Other Short Term Investments | $55,889,000 | $9,198,000 | $16,288,000 | $43,260,000 |
| Current Provisions | - | - | $7,858,000 | $8,312,000 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $416,000 | $4,904,000 | $-18,879,000 | $-18,873,000 |
| Operating Activities | ||||
| Operating Cash Flow | $20,115,000 | $8,431,000 | $-12,498,000 | $-8,488,000 |
| Cash Flow From Continuing Operating Activities | $20,115,000 | $8,431,000 | $-12,498,000 | $-8,488,000 |
| Operating Gains Losses | $-9,803,000 | $-15,156,000 | $1,227,000 | $1,518,000 |
| Investing Activities | ||||
| Capital Expenditure | $-19,699,000 | $-3,527,000 | $-6,381,000 | $-10,385,000 |
| Investing Cash Flow | $-71,539,000 | $58,300,000 | $17,837,000 | $-58,117,000 |
| Cash Flow From Continuing Investing Activities | $-71,539,000 | $58,300,000 | $17,837,000 | $-58,117,000 |
| Net Other Investing Changes | $-886,000 | $-2,068,000 | $-4,856,000 | $-3,536,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $0 | $10,244,000 | $0 |
| Financing Cash Flow | $-10,924,000 | $-6,783,000 | $10,591,000 | $16,316,000 |
| Cash Flow From Continuing Financing Activities | $-10,924,000 | $-6,783,000 | $10,591,000 | $16,316,000 |
| Net Other Financing Charges | $-942,000 | $-377,000 | $338,000 | $-1,843,000 |
| Net Common Stock Issuance | $0 | $0 | $10,244,000 | $0 |
| Common Stock Issuance | $0 | $0 | $10,244,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-10,000,000 | $-6,608,000 | $-498,000 | $-2,164,000 |
| Interest Paid Supplemental Data | $762,000 | $1,608,000 | $1,927,000 | $586,000 |
| End Cash Position | $33,038,000 | $95,386,000 | $35,438,000 | $19,473,000 |
| Beginning Cash Position | $95,386,000 | $35,438,000 | $19,473,000 | $69,870,000 |
| Effect Of Exchange Rate Changes | $0 | $0 | $35,000 | $-108,000 |
| Changes In Cash | $-62,348,000 | $59,948,000 | $15,930,000 | $-50,289,000 |
| Proceeds From Stock Option Exercised | $18,000 | $202,000 | $507,000 | $323,000 |
| Net Issuance Payments Of Debt | $-10,000,000 | $-6,608,000 | $-498,000 | $17,836,000 |
| Net Long Term Debt Issuance | $-10,000,000 | $-6,608,000 | $-498,000 | $17,836,000 |
| Long Term Debt Payments | $-10,000,000 | $-6,608,000 | $-498,000 | $-2,164,000 |
| Net Investment Purchase And Sale | $-74,470,000 | $3,503,000 | $29,074,000 | $-44,196,000 |
| Sale Of Investment | $41,593,000 | $21,918,000 | $56,169,000 | $8,920,000 |
| Purchase Of Investment | $-116,063,000 | $-18,415,000 | $-27,095,000 | $-53,116,000 |
| Net Business Purchase And Sale | $23,516,000 | $60,392,000 | $0 | $0 |
| Sale Of Business | $23,516,000 | $73,431,000 | $0 | $0 |
| Purchase Of Business | $0 | $-13,039,000 | $0 | $0 |
| Net Intangibles Purchase And Sale | $-10,221,000 | $-300,000 | $0 | $0 |
| Purchase Of Intangibles | $-10,221,000 | $-300,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-9,478,000 | $-3,227,000 | $-6,381,000 | $-10,385,000 |
| Purchase Of PPE | $-9,478,000 | $-3,227,000 | $-6,381,000 | $-10,385,000 |
| Change In Working Capital | $-8,909,000 | $227,000 | $1,467,000 | $-14,905,000 |
| Change In Other Working Capital | $264,000 | $-258,000 | $97,000 | $-260,000 |
| Change In Other Current Liabilities | $5,000 | $-528,000 | $-454,000 | $-1,086,000 |
| Change In Payables And Accrued Expense | $-5,135,000 | $5,538,000 | $-5,112,000 | $3,727,000 |
| Change In Accrued Expense | $-1,144,000 | $6,485,000 | $2,002,000 | $1,787,000 |
| Change In Payable | $-3,991,000 | $-947,000 | $-7,114,000 | $1,940,000 |
| Change In Account Payable | $-2,086,000 | $26,000 | $-8,425,000 | $414,000 |
| Change In Tax Payable | $-1,905,000 | $-973,000 | $1,311,000 | $1,526,000 |
| Change In Income Tax Payable | $-1,905,000 | $-973,000 | $1,311,000 | $1,526,000 |
| Change In Prepaid Assets | $-3,039,000 | $-2,407,000 | $137,000 | $26,000 |
| Change In Inventory | $-1,268,000 | $781,000 | $-8,552,000 | $-6,559,000 |
| Change In Receivables | $264,000 | $-2,899,000 | $15,351,000 | $-10,753,000 |
| Changes In Account Receivables | $264,000 | $-2,899,000 | $15,351,000 | $-10,753,000 |
| Other Non Cash Items | $17,396,000 | $424,000 | $-6,891,000 | $-1,084,000 |
| Stock Based Compensation | $22,993,000 | $30,923,000 | $33,245,000 | $25,334,000 |
| Unrealized Gain Loss On Investment Securities | $-983,000 | $4,074,000 | $0 | $-697,000 |
| Asset Impairment Charge | $0 | $0 | $15,485,000 | $110,364,000 |
| Amortization Of Securities | $-736,000 | $-474,000 | $-1,262,000 | $-447,000 |
| Deferred Tax | $65,000 | $-64,000 | $-62,000 | $-5,238,000 |
| Deferred Income Tax | $65,000 | $-64,000 | $-62,000 | $-5,238,000 |
| Depreciation Amortization Depletion | $4,687,000 | $8,661,000 | $12,295,000 | $16,472,000 |
| Depreciation And Amortization | $4,687,000 | $8,661,000 | $12,295,000 | $16,472,000 |
| Amortization Cash Flow | $2,434,000 | $3,501,000 | $5,181,000 | $9,697,000 |
| Amortization Of Intangibles | $2,434,000 | $3,501,000 | $5,181,000 | $9,697,000 |
| Depreciation | $2,253,000 | $5,160,000 | $7,114,000 | $6,775,000 |
| Gain Loss On Sale Of PPE | $11,000 | $154,000 | $633,000 | $745,000 |
| Gain Loss On Sale Of Business | $-10,324,000 | $-15,877,000 | $0 | $0 |
| Net Income From Continuing Operations | $-4,595,000 | $-20,184,000 | $-68,002,000 | $-139,805,000 |
| Issuance Of Debt | - | $0 | $0 | $20,000,000 |
| Long Term Debt Issuance | - | $0 | $0 | $20,000,000 |
| Net Short Term Debt Issuance | - | - | $0 | $0 |
| Short Term Debt Payments | - | - | $0 | $0 |
| Short Term Debt Issuance | - | - | $0 | $0 |
| Sale Of PPE | - | - | $0 | $0 |
| Earnings Losses From Equity Investments | - | - | - | - |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-06-17